CRIS Current Research Information System

DOMENICALI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.196
EU - Europa 4.791
AS - Asia 2.740
AF - Africa 275
SA - Sud America 25
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 15.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.179
GB - Regno Unito 1.184
IT - Italia 948
CN - Cina 871
VN - Vietnam 716
SG - Singapore 713
SE - Svezia 685
DE - Germania 516
IN - India 243
IE - Irlanda 219
UA - Ucraina 207
FR - Francia 203
RU - Federazione Russa 200
CH - Svizzera 190
TG - Togo 126
BG - Bulgaria 100
ZA - Sudafrica 96
EE - Estonia 94
JO - Giordania 73
FI - Finlandia 50
AT - Austria 40
IR - Iran 40
ES - Italia 39
CI - Costa d'Avorio 33
NL - Olanda 29
BE - Belgio 25
CA - Canada 15
GR - Grecia 15
ID - Indonesia 15
HK - Hong Kong 13
JP - Giappone 13
HR - Croazia 11
AU - Australia 10
SC - Seychelles 10
LB - Libano 9
UZ - Uzbekistan 9
BR - Brasile 8
CL - Cile 8
NG - Nigeria 7
PL - Polonia 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
RO - Romania 6
SK - Slovacchia (Repubblica Slovacca) 4
DK - Danimarca 3
IL - Israele 3
PT - Portogallo 3
EU - Europa 2
KZ - Kazakistan 2
LT - Lituania 2
MX - Messico 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
TH - Thailandia 2
TR - Turchia 2
AM - Armenia 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
KR - Corea 1
LU - Lussemburgo 1
MA - Marocco 1
MN - Mongolia 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
TW - Taiwan 1
Totale 15.041
Salva come PNG Salva come JPEG
Città #
Southend 1.064
Fairfield 874
Chandler 699
Singapore 624
Ashburn 553
Dong Ket 470
Santa Clara 467
Woodbridge 445
Seattle 367
Houston 363
Wilmington 361
Cambridge 322
Princeton 273
Bologna 268
Ann Arbor 236
Dublin 218
Boardman 215
Bern 178
Lomé 126
Jacksonville 120
Nanjing 111
Westminster 107
Sofia 99
Padova 95
Berlin 81
Amman 73
San Diego 62
Saint Petersburg 60
Beijing 57
Milan 57
Shenyang 57
Jinan 55
Turin 53
Florence 45
Helsinki 41
New York 41
Hebei 40
Changsha 36
Shanghai 35
Abidjan 33
Los Angeles 31
Redmond 30
Dearborn 29
Mülheim 29
Nanchang 29
Vienna 28
Tianjin 26
Jiaxing 23
Medford 23
Norwalk 23
Bremen 21
Brussels 21
Guangzhou 21
Paris 20
Redwood City 20
Olalla 19
Barcelona 18
Ningbo 18
Falls Church 17
Mountain View 17
Hangzhou 15
Jakarta 15
Zhengzhou 15
Ardabil 14
Chicago 13
Falkenstein 13
Rome 13
Washington 13
Bühl 12
Des Moines 12
Xi'an 12
Hong Kong 11
London 11
Parma 11
Shenzhen 11
Wuhan 11
Fuzhou 10
Kunming 10
Lanzhou 10
Leganés 10
Mahé 10
Taiyuan 10
Tokyo 10
Zanjan 10
Haikou 9
Moscow 9
Munich 9
Phoenix 9
Reggio Emilia 9
San Francisco 9
Verona 9
Amsterdam 8
Lappeenranta 8
Leawood 8
Shijiazhuang 8
Abeokuta 7
Hefei 7
Modena 7
Suzhou 7
Taizhou 7
Totale 10.356
Salva come PNG Salva come JPEG
Nome #
Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study 219
A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. 189
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 187
A novel model of CCl4-induced cirrosi with ascites in the mouse. 186
Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis. 185
Albumin homodimers in patients with cirrhosis: clinical and prognostic relevance of a novel identified structural alteration of the molecule. 183
Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study 182
A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV-infected individuals with occult HBV infection. 180
Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis 178
BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. 166
null 164
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 161
A novel sodium overload test predicting ascites decompensation in rats with CCL4-induced cirrhosis. 152
Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischemia-reperfusion injury complicated by endotoxemia. 149
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 149
Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. 148
A fast and validated mass spectrometry method for the evalutation of human serum albumin structural modifications in the clinical field. 148
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 148
The nutritional status modulates preservation-reperfusion injury in rat fatty liver. 145
Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. 145
The reduced tolerance of rat fatty liver to ischemia-reperfusion is associated to mitochondrial oxidative injury. 144
Clinical indications for the albumin use: Still a controversial issue. 144
Mass spectrometry characterization of circulating human serum albumin microheterogeneity in patients with alcoholic hepatitis. 143
Acute-on-chronic liver failure is a distinct syndrome developing in patients with acute dcompensation of cirrhosis. 143
null 142
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 141
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 141
An innovative hyperbaric hypothermic machine perfusion protects the liver from experimental preservation injury 139
Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients 138
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 138
Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis. 137
Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study 137
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer 136
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 135
Portal vein arterialization for the treatment of post resection acute liver failure in the rat. 135
Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. 134
Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat. 134
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 131
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. 129
How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. 129
Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis. 128
Metabolic disorders across hepatocellular carcinoma in Italy 128
Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 127
The endocannabinoid system and liver diseases. 125
Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. 124
Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. 124
A brief up-date of the use of sodium exybate for the treatment of alcohol use disorders. 124
External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study 121
Simple and rapid LC-MS method for the determination of circulating albumin microheterogeneity in veal calves exposed to heat stress 120
Posttranscriptional changes of serum albumin: clinical and prognostic meaning in hospitalized patients with cirrhosis. 120
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. 119
C-type natriuretic peptide (CNP) favours natriuresis in pre-ascitic cirrhotic patients. 118
Dorsal acoustic windows may ameliorate liver ultrasound in patients with liver disease and meteorism/obesity/ascites. 118
Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis 118
QT Interval Correction in Patients with Cirrhosis 117
null 117
Gioco responsabile e comportamenti di salute: un progetto di ricerca e intervento in Emilia-Romagna 115
Portal vein arterialization increases liver regeneration in acute liver failure induced by extended hepatectomy or toxin administration in the rat 114
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. 114
Prognostic Role of Bacterial and Fungal Infections in Patients with Liver Cirrhosis with and without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study 114
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis. 111
Years of life that could be saved from prevention of hepatocellular carcinoma. 111
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 111
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF) 110
Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population. 109
The role of the endocannabinoid system in liver diseases. 107
Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis 107
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 107
Increased anandamide-induced relaxation in mesenteric arteries of cirrhotic rats. Role of cannabinoid and vanilloid receptors. 106
Successful treatment of CCL4-induced acute liver failure with portal vein arterialization in the rat. 104
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study 104
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis. 104
Hyposplenism as a cause of pneumococcal meningoencephalitis in an adult patient with coeliac disease 103
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study. 103
Transthoracic electrical bioimpedance: a non-invasive technique for the evaluation of the hemodynamic alterations in patients with liver cirrhosis. 103
Effect of the cannabinoid CB1 receptor antagonist SR141716 in a rat model of liver inflammation 101
Technical aspects of portal vein arterialization for acute liver failure: from rat lab to man. 100
Effetto dell’antagonismo farmacologico dei recettori per gli endocannabinoidi sull’equilibrio idrosodico nella cirrosi epatica. Prospettive terapeutiche. [Effect of the pharmacological antagonism of the endocannabinoid receptors on the sodium balance in liver cirrhosis] 99
Prevalence of and risk factors for fatty liver in the general population of Northern Italy: The Bagnacavallo Study 99
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres. 98
L’apparato cardiovascolare dell’anziano. 96
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 95
A web-based group treatment for patients with alcoholic liver diseases at the time of the COVID-19 pandemic 95
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 94
Portal hypertension and liver cirrhosis in rats: effect of the beta3-adrenoceptor agonist SR58611A. 94
Mortality risk in a cohort of Italian alcoholic individuals treated for alcohol dependence. 94
Regional cerebral hypoperfusion in patients with celiac disease. 93
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1-receptor in a rat model of CCl4-induced advanced cirrhosis. 92
Relationship between ghrelin levels, alcohol craving, and nutritional status in current alcoholic patients. 91
Development and validation of a scoring system that includes corrected QT interval for risk analysis of patients with cirrhosis and gastrointestinal bleeding 91
The renin-angiotensin-aldosterone system in cirrhosis. 90
Diagnosis and Treatment of Alcohol Use Disorder in Patients With End-Stage Alcoholic Liver Disease. 90
Could Inflammatory Indices and Metabolic Syndrome Predict the Risk of Cancer Development? Analysis from the Bagnacavallo Population Study 90
null 88
Response to The reduced CO2+ -binding ability of ischaemia-modified albumin is unlikely to be because of oxidative modification of the N-terminus" 87
Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF) 87
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 87
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches 86
Muscle atrophy in advanced cirrhosis: a negleted factor in the evaluation of regional hemodinamycs 85
Impairment of mitochondrial oxidative phosphorylation in fatty liver exposed to preservation – reperfusion injury 84
Totale 12.425
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.410
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.176 0 0 0 0 0 340 434 427 480 225 107 163
2020/20211.999 328 132 31 77 37 72 70 114 186 101 99 752
2021/20222.721 278 94 140 219 204 136 100 174 114 192 676 394
2022/20233.085 280 455 163 365 192 228 89 182 528 70 243 290
2023/20241.050 69 153 91 95 74 200 55 87 46 66 77 37
2024/20252.210 127 567 333 305 689 189 0 0 0 0 0 0
Totale 15.442